Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Mining gains offset by falls from airline, healthcare stocks

Tue, 07th Oct 2014 11:36

Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals.The FTSE 100 was trading 0.6% lower at 6,522 by around midday.Nervousness ahead of the start of third-quarter earnings season in the States was also causing investors to tread cautiously, with US stock futures trading firmly lower ahead of the opening bell.German, UK industrial productionEconomic news wasn't helping sentiment in early deals after it was revealed that German industrial production dropped by 4% in August, pulling back after a revised 1.6% increase in July. The consensus estimate was for a lesser decline of 1.5%.The figures followed further weak figures from Germany on Monday which showed that factory orders in August slumped 5.7% after 4.9% growth in July. This was the biggest slump since 2009.Closer to home, UK industrial production was flat in August after a 0.4% expansion in July, though this was in line with estimates.Analysts at Capital Economics said that the industrial recovery in Britain is "still lacking momentum" and the data showed that the economic recovery "remained unbalanced in the third quarter".Rio Tinto jumps after Glencore approach revealedRio Tinto rose strongly after confirming that Glencore had approached the company in July about a "possible combination", though the board had rejected the approach as it "was not in the best interests of [...] shareholders".Rio Tinto was responding to press speculation after Bloomberg earlier said that Glencore was in talks with Rio Tinto's biggest shareholder, Chinalco, to gauge its interest in a potential deal. These discussions had taken place in recent weeks, sources said.Others in the sector were also on the rise, including Antofagasta, Randgold Resources and Centamin. Antofagasta was given a lift by an upgrade to 'neutral' by Nomura.However, leading the downside were airlines Easyjet and IAG after a strong performance the previous session, with the latter especially hit by the news of a person contracting the Ebola virus in Spain.Pharmaceuticals were also under the weather after Morgan Stanley cut its rating on the European healthcare sector to 'underweight'. Astrazeneca, Glaxosmithkline and Shire were all lower.Tesco was continuing to recover after its recent slump after having asked another member of its senior management to step down in the wake of an investigation into accounting practices. The company was also reportedly contacted by private equity buyout company TPG about potentially acquiring Dunnhumby, the data analysis unit that runs its Clubcard loyalty scheme.Oil and gas group Cairn Energy was a high riser on the FTSE 250 after discovering oil at its FAN-1 exploration well offshore Senegal, causing shares to surge. The find "materially upgrades the prospectivity" of the Sangomar Deep Block, the company said.However, telecoms tester Spirent Communications saw shares sink after it warned that revenues and profits in the second half would be lower than previously guided due to lower demand in the US and China.Market MoverstechMARK 2,757.48 -1.27%FTSE 100 6,522.39 -0.63%FTSE 250 15,144.22 -0.87%FTSE 100 - RisersRio Tinto (RIO) 3,139.50p +4.75%Tesco (TSCO) 182.30p +3.14%Anglo American (AAL) 1,377.50p +2.19%Randgold Resources Ltd. (RRS) 4,200.00p +1.13%Standard Chartered (STAN) 1,140.50p +1.02%Admiral Group (ADM) 1,299.00p +0.70%Aberdeen Asset Management (ADN) 395.50p +0.64%Antofagasta (ANTO) 710.00p +0.50%Sports Direct International (SPD) 616.50p +0.41%Coca-Cola HBC AG (CDI) (CCH) 1,331.00p +0.30%FTSE 100 - FallersInternational Consolidated Airlines Group SA (CDI) (IAG) 349.70p -5.82%easyJet (EZJ) 1,400.00p -4.57%Carnival (CCL) 2,400.00p -3.81%Schroders (SDR) 2,287.00p -2.72%InterContinental Hotels Group (IHG) 2,271.00p -2.49%TUI Travel (TT.) 388.20p -2.29%London Stock Exchange Group (LSE) 1,821.00p -1.94%Ashtead Group (AHT) 995.00p -1.78%Petrofac Ltd. (PFC) 965.00p -1.78%Whitbread (WTB) 4,067.00p -1.76%FTSE 250 - RisersCairn Energy (CNE) 194.30p +8.00%Tullett Prebon (TLPR) 265.60p +2.55%Zoopla Property Group (WI) (ZPLA) 219.60p +1.34%Centamin (DI) (CEY) 58.60p +1.30%Lonmin (LMI) 170.00p +1.25%Countrywide (CWD) 471.60p +1.20%Merlin Entertainments (MERL) 348.70p +0.87%Kazakhmys (KAZ) 252.00p +0.72%Ted Baker (TED) 2,013.00p +0.65%Hikma Pharmaceuticals (HIK) 1,770.00p +0.51%FTSE 250 - FallersSpirent Communications (SPT) 79.70p -19.21%Just Retirement Group (JRG) 120.90p -4.28%Thomas Cook Group (TCG) 114.50p -3.78%Hunting (HTG) 846.00p -3.42%Fidessa Group (FDSA) 2,236.00p -3.20%EnQuest (ENQ) 99.85p -2.96%Enterprise Inns (ETI) 118.10p -2.88%Telecity Group (TCY) 713.50p -2.86%Spirax-Sarco Engineering (SPX) 2,759.00p -2.41%Big Yellow Group (BYG) 498.70p -2.41%
More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.